IDYA Stock Surges 39% After Eye Cancer Drug Extends Survival in Key Trial
IDEAYA Biosciences has suddenly moved from being a speculative biotech name to one of the market’s most closely watched cancer stocks after a sharp premarket rally followed a major clinical…







